fda compounding semaglutide warning letters october 2025 Beyond the Headlines: to GLP-1 Compounders FDA issued 25 warning letters

The number of beneficiaries eligible for the Medicare GLP-1 Bridge is unknown, but a previous KFF analysis estimated that close to 14 million Medicare beneficiaries had a diagnosis of overweight or obesity in 2020 (BMI of 25-29.9 and 30 or more, respectively), though applying the specific criteria that determine eligibility for the Medicare GLP-1 Bridge would reduce that number

North America dominates the market with share of 73% CAGR in 2022, and is anticipated to grow with 17% CAGR over the forecast period 2023-2029

Staying hydrated helps reduce potential side effects like headaches or fatigue

It enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system effects